Real-world pancreatic function recovery and fluctuation in young children with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis · 2025
DOI: 10.1016/j.jcf.2025.09.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Laura Schembri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College, London, UK. Electronic …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quinolones, Aminophenols, Benzodioxoles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Clinical trials showed improved faecal elastase (FE-1) levels in younger children with cystic fibrosis (cwCF) on elexacaftor/tezacaftor/ivacaftor (ETI). Lower sweat chloride has been linked to better clinical outcomes in people with CF. Our previous work showed increased vitamin A levels in cwCF aged 5-15 years. We aimed to evaluate changes in FE-1 and vitamin levels and explore associations between sweat chloride and FE-1, in 2-6-year-olds starting ETI in a real-world setting. METHODS: In a large UK paediatric specialist CF centre, cwCF newly eligible for ETI when UK licensing age decreased to 2 years were included. Baseline vitamin A, D, E and FE-1 levels were collected retrospectively. Post ETI, FE-1, vitamin and sweat chloride levels were collected prospectively. RESULTS: 51/68 eligible patients were included. Median age on starting ETI was 4.1 (range 2.0-6.5) years. 12/43 (28 %) of pancreatic insufficient (PI) patients became pancreatic sufficient (PS) 6 months after ETI (p = 0.0005); 3 reverted to PI by 12 months, and 1 other patient became PS by 12 months. Enzymes were reduced or stopped for most children who became PS. Change in FE-1 negatively correlated with post ETI sweat chloride level (Spearman's ρ -0.49, p = 0.007). There was a significant increase in median vitamin D levels (p = 0.007) but no significant changes in vitamins A or E; particularly, high vitamin A levels were not seen. CONCLUSIONS: Reversal of PI appears possible in preschool cwCF, but may not be sustained. Enzyme adjustments should be made cautiously, and monitoring of symptoms and FE-1 continued.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College, London, UK. Electronic address: l.schembri1@nhs.net.
- Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK.
- National Heart and Lung Institute, Imperial College, London, UK; Department of Paediatric Pharmacy, Royal Brompton Hospital, London, UK.
- National Heart and Lung Institute, Imperial College, London, UK; Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
- Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
Zitieren
APA
Schembri, L., Jones, D., Bentley, S., Carr, S., & Balfour-Lynn, I. (2025). Real-world pancreatic function recovery and fluctuation in young children with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.09.004
Vancouver
Schembri L, Jones D, Bentley S, Carr S, Balfour-Lynn I. Real-world pancreatic function recovery and fluctuation in young children with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.09.004
BibTeX
@article{Schembri2025,
author = {Schembri, Laura and Jones, Delyth and Bentley, Siân and Carr, Siobhán and Balfour-Lynn, Ian},
title = {Real-world pancreatic function recovery and fluctuation in young children with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2025.09.004}
}
EUVIMED